Fraxel re:store DUAL Laser System MC-SYS-SR1500-D-USRRecalls & reported problems
Solta Medical · Re:Store DUAL Domestic, Refurbished · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816995027010), received between May 22, 2024 and May 22, 2024 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Impaired Healing1
- Skin Infection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMay 22, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A USER FACILITY REPORTED PROLONGED HEALING WITH AN INFECTION ON THE NECK 6 DAYS POST FRAXEL DUAL TREATMENT TO THE FACE AND NECK. THE REPORT NOTED THAT THE PATIENT HAD ANOTHER PROCEDURE (BOTOX) WITHIN THE LAST NINETY DAYS ON THE SAME AREA AS TREATMENT, BUT NOT ON THE SAME AREA AS THE EVENT. THIS WAS THE PATIENT'S FIRST FRAXEL PROCEDURE. THE PATIENT WAS PRESCRIBED AN UNKNOWN ANTIBIOTIC FOR THE INFECTION. THE CURRENT STATUS WAS OTHERWISE REPORTED TO BE NORMAL. THE OUTCOME WAS ALSO REPORTED THAT A PERMANENT SCAR IS UNLIKELY; HOWEVER, IT WAS NOTED AS UNCERTAIN AT THIS TIME. NO PICTURE WAS AVAILABLE TO REVIEW DESPITE MULTIPLE REQUESTS. NO OTHER TREATMENTS (BESIDES THE ONE REPORTED) WERE BEING PERFORMED IN THE SAME AREA WHERE THE SYMPTOMS OCCURRED. THE PATIENT WAS USING ASLKAN NECTAR AND MOISTURIZER- IT WAS UNSPECIFIED IF IT WAS USED BEFORE, DURING, OR AFTER THE TREATMENT. THE PATIENT HAD ¿SIGNIFICANT SUN DAMAGE¿ PRIOR TO THE TREATMENT AND THE SKIN TYPE RECORDED FOR THE PATIENT IS FITZPATRICK SKIN TYPE IV. THE HIGHEST ENERGY LEVEL USED WAS 10 MJ WITH 8 PASSES ON THE FACE AND NECK. THERE WERE OVERLAPPING PASSES. THERE WERE NO SYSTEM ERRORS THAT OCCURRED NOR WAS ANYTHING OUT OF THE ORDINARY
Patient problems: Impaired Healing; Skin Infection
MAUDE report 19372845 ↗
Other Powered Laser Surgical Instrument devices
- Moxy 0010-2400Boston Scientific Corporation · Powered Laser Surgical Instrument4,572 reports
- SOLTIVE TFL-PLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls450 reports
- Flexiva TracTip M0068403960Boston Scientific Corporation · Powered laser surgical instrument562 reports
- Moses™ AC-10030100Lumenis Ltd. · Powered Laser Surgical Instrument532 reports
- Flexiva M0068403910Boston Scientific Corporation · Powered laser surgical instrument376 reports
- Visualase 9735542Medtronic Navigation, Inc. · Powered laser surgical instrument1 recall2 deaths311 reports
- SOLTIVE TFL-SLSGyrus ACMI, LLC · Powered laser surgical instrument6 recalls33 reports
- NeuroBlate® System 20980Monteris Medical Inc · Powered laser surgical instrument7 deaths296 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page